Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Revenue

In the fiscal year ending June 30, 2025, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 1.51B EGP with 72.93% growth. Memphis Pharmaceuticals & Chemical Industries had revenue of 410.53M in the quarter ending June 30, 2025, with 98.01% growth.

• Revenue: 1.51B
• Revenue Growth: +72.93%
• P/S Ratio: 3.30
• Revenue / Employee: 10.47M
• Employees: 144
• Market Cap: 4.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.51B	635.90M	72.93%
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%
Jun 30, 2021	518.11M	29.70M	6.08%